Top Markets
Coin of the day
Clearbridge Health Limited Clearbridge Health Limited

Clearbridge Health Limited

1H3
Classifica tra le azioni #32402
Established in 2010 and headquartered in Singapore, Clearbridge Health Limited... Established in 2010 and headquartered in Singapore, Clearbridge Health Limited operates as an investment holding company, delivering diverse healthcare solutions globally, including in Singapore, the Philippines, Hong Kong, and Malaysia. The firm's activities are organized into three key divisions: Strategic Investments, Healthcare Systems, and Medical Clinics/Centres. Its extensive range of services encompasses advanced imaging diagnostics, such as general X-ray, CT scans (including dental cone beam), mammography, MRI, and ultrasound. Furthermore, Clearbridge offers general wellness screenings for conditions like diabetes, high blood pressure, and elevated cholesterol, alongside vaccination programs. Specialized care includes renal treatment, clinical services, aesthetic procedures, and dental and orthodontic services. Beyond patient care, the company provides consultancy to healthcare organizations and is involved in the wholesale supply of medicinal and pharmaceutical products.
Prezzo delle azioni
$0.00158262
Ultima sincronizzazione: 2026-08-17
Capitalizzazione di mercato
$10.20M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-
Paese
SG
Scambia Clearbridge Health Limited (1H3)

Categoria

Utile per Clearbridge Health Limited (1H3)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Clearbridge Health Limited, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Clearbridge Health Limited dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
$7.61B -
US
$4.76B -
US
- -
CN
$-252.70M -
US
$1.42B -
US